Ixekizumab-induced interstitial lung disease: a case report confirmed by transbronchial lung cryobiopsy

• Main Authors: Shota Kaburaki (Author), Naoko Okada (Author), Toru Tanaka (Author), Koichiro Kamio (Author), Yosuke Tanaka (Author), Yasuhiro Terasaki (Author), Kazuo Kasahara (Author), Masahiro Seike (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Ixekizumab, an interleukin-17A (IL-17A) inhibitor used in psoriasis treatment, has been linked to drug-induced interstitial lung disease (DI-ILD). The pathophysiological mechanisms and histopathological features of this adverse effect remain poorly documented.Case Presentation: A 69-year...